Search

Displaying results 6231 - 6240 of 10000 in total
  1. Drug

    Cyclachaena xanthifolia pollen

    go.drugbank.com/drugs/DB10929
    Approved

    Cyclachaena xanthifolia pollen is the pollen of the Cyclachaena xanthifolia plant. Cyclachaena xanthifolia pollen is mainly used in allergenic testing.

  2. Drug

    Ambrosia ambrosioides pollen

    go.drugbank.com/drugs/DB10947
    Approved

    Ambrosia ambrosioides pollen is the pollen of the Ambrosia ambrosioides plant. Ambrosia ambrosioides pollen is mainly used in allergenic testing.

  3. Drug

    Phoenix dactylifera pollen

    go.drugbank.com/drugs/DB10950
    Approved

    Phoenix dactylifera pollen is the pollen of the Phoenix dactylifera plant. Phoenix dactylifera pollen is mainly used in allergenic testing.

  4. Drug

    Phalaris minor pollen

    go.drugbank.com/drugs/DB10963
    Approved

    Phalaris minor pollen is the pollen of the Phalaris minor plant. Phalaris minor pollen is mainly used in allergenic testing.

  5. Drug

    Ulmus parvifolia pollen

    go.drugbank.com/drugs/DB11005
    Approved

    Ulmus parvifolia pollen is the pollen of the Ulmus parvifolia plant. Ulmus parvifolia pollen is mainly used in allergenic testing.

  6. Drug

    Schinus terebinthifolia pollen

    go.drugbank.com/drugs/DB21762
    Approved

    Schinus terebinthifolia pollen is the pollen of the Schinus terebinthifolia plant. Schinus terebinthifolia pollen is mainly used in allergenic testing.

  7. Drug

    Interleukin-7

    go.drugbank.com/drugs/DB11997
    Investigational

    Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.

    Synonyms: IL-7
  8. Drug

    Imidapril

    go.drugbank.com/drugs/DB11783
    Investigational

    Imidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant.

    Categories: Agents Acting on the Renin-Angiotensin System
  9. Drug

    IR502

    go.drugbank.com/drugs/DB06463
    Experimental

    IR502 (Zorcell) is a potential treatment for psoriasis.

  10. Drug

    AGS-005

    go.drugbank.com/drugs/DB05741
    Experimental

    AGS-005 is a personalized dendritic cell-based immunotherapy, with optimized immune response characteristics, that is designed to stimulate the patient's immune system to target and destroy the patient's